Document:

Q1 2014 10-Q Exhibit 10.2

Exhibit 10.2

January 29, 2014

Robin Friedman

   27 Weaver Drive

   Martinsville , NJ 08836

Dear Robin:

On behalf ofNPS Pharmaceuticals, Inc. ("NPS"), I am pleased to offer you employment as Senior Vice President, Human Resources
reporting Dr. Francois Nader, President & Chief Executive Officer.  Your employment will
begin at an annual salary of $330,000.00, currently payable in bi-weekly installments. We propose that your starting date be on March 17, 2014 or sooner as your circumstances allow.

Your annual incentive target will be 38% (weighted 75% on Company performance and 25% on Individual performance) of base salary
under the terms of the NPS Short Term Incentive (STI) Plan. The actual amount of this incentive, or whether you receive an incentive at all, is not guaranteed and is
based on your actual regular base earnings.  Also, this target amount is subject to change at the discretion of the Board of Directors.
Eligibility for this plan will begin in 2014.

You will also receive a sign-on bonus equal to $20,000.  The sign-on bonus will be paid in the first pay cycle after
your first 30 days of employment.  Your bonus is subject to federal and state taxes at the standard rate. In the event that you voluntarily resign or are terminated for
cause within one year of your employment date, you must return the full sign-on bonus to
NPS.

As an NPS employee you will be eligible to receive equity grants under the Company's
equity plans.  You will be awarded an initial new hire equity grant with a value of$800,000 split 60% into stock
options and 40% into RSUs.  The actual number of options you receive will be based on the estimated Black-Scholes value of each share option.  The exercise price
of the options and the actual number ofRSUs you receive will be based on the price for shares ofNPS common stock as quoted on the NASDAQ Stock Market at
market close on the date the options are granted.  The grants will be issued on the 15th or next available business day of the month after your month of hire.  All
grants are subject to approval by the Board of Directors.  Your new hire stock option grant will vest over four years, as follows:  25% becomes vested on the first
anniversary of the grant and then 6.25% every three months for the next 3 years.  In addition,
you will also receive RSUs on the 15th or next available business day of the month after your month of hire. Your RSUs will vest
113 each year over a 3 year period.

I can also confirm that "change  in control" severance protection (18 months base salary and STI) exists for
you  as  per the  rules of the enclosed "NPS Pharmaceuticals,  Inc. Change in Control Severance Pay Plan".  This plan
is subject to an annual review by the Board of Directors and may be changed at their discretion.    In addition, I confmn  that you would be eligible
for 18 months of base salary severance (and Company paid COBRA healthcare-subjectto your COBRA
eligibility)  in the event that your employment with NPS is terminated without cause or if you terminate your employment for Good  Reason.  For purposes  of  this
agreement, Good Reason shall mean (i) relocation  of the principal place at which your
duties are to be performed to a location more than 30 miles from 550 Hills Drive, Bedminster, NJ 07921; (ii) any reduction in your base pay or your bonus potential
other than a reduction of a proportionally  like amount affecting all other senior executives  of NPS,
(iii) a change in your reporting  responsibilities, so that you no longer report directly  to the Chief
Executive of NPS or (iv) a change in title from Senior Vice
President, Human Resources.

  550 Hills Drive, 3m Floor, Bedminster, NJ 07921 - phone 908-450-5300- fax 908-450-5351 - www.npsp.com 

In addition, NPS provides U.S. employees with the following benefits package, which may be revised from time to time.

	Medical insurance coverage for you and your legal dependents as defmed by The NPS Medical Plan.
	Dental insurance coverage for you and your legal dependents as defined by The NPS Dental Plan.
	Long Term Care insurance.
	Short-term disability coverage.
	Regular life insurance in the amount of one times your base salary with a minimum of $50,000 and a maximum of $200,000.
	Accidental death and dismemberment  insurance in the amount of one times your base salary with a minimum of $50,000 and a maximum of $200,000.
	Long-term disability coverage.
	A 401k plan, subject to that plan's rules.  Currently NPS will match 100% of your contributions up to 3% of your annual salary and 50% of your contributions
for the next 3%. NPS Pharmaceuticals' contributions will be 0% vested until an employee has worked for NPS Pharmaceuticals for 3 years, after which a participant
will be 100% vested.
	The option to participate in the 125 Cafeteria Plan which includes Dependent Care and Health Care Flexible Spending Accounts.
	Annual Paid Time Off (PTO) accrual of 7.7 hours per full pay period worked for a total of 25 days per year.
	Ten paid holiday days each year

You will be required to observe NPS policies and procedures applicable to employees. Your first 90 days of employment will be
considered an "introductory period".  Within this period, we shall assess and evaluate your performance and you will also be working closely with your supervisor to
closely monitor your work and advise improvement accordingly.

New Jersey is an employment-at-will state and as with all employees ofNPS, your employment will be at-will and there is no fixed or guaranteed duration of your
employment. This offer of employment is conditional upon the submission of appropriate documentation to work in the United States within three business days of
your first day of employment and
the signing of the Code of Business Conduct and Ethics as well as the Employee Policy Agreement Concerning Invention
  Assignment, Non-Disclosure, and Non-Competition.  Copies of appropriate forms are enclosed or will be provided separately.  All policies are subject to change.

This offer is contingent upon successful completion of reference checks, drug screening and background verification. The outcome of
these checks and verification, at the absolute discretion ofNPS, must be considered by NPS
to be satisfactory. We recommend that you do not resign from your current employer until you have been advised by NPS that your background check and other
verifications have been successfully completed.  Please sign and return this offer letter by Friday, January 31, 2014.

By accepting this offer you represent that you are not a party to any agreement or employment agreement that would interfere with your
employment at NPS.

During orientation you will be asked to complete your new-hire paperwork.Please bring two forms of government issued
identification with you, such as a U.S. Passport, Driver's License, or a Social Security card; one form of identification needs to have your photograph.

I look forward to your response and to the significant contribution you will make to our efforts. Please call me if you have any questions.

Sincerely,

/s/ Glenn Melrose  

Glenn Melrose  

Sr. Vice President, Human Resources 

Please indicate your acceptance of this employment offer by signing below:

	
/s/ Robin D. Friedman          

Robin Friedman

	
January 30, 2014           

Date

  550 Hills Drive, 3m Floor, Bedminster, NJ 07921 - phone 908-450-5300- fax 908-450-5351 - www.npsp.comQ1 2014 10-Q Exhibit 10.3

Exhibit 10.3

EMPLOYMENT AGREEMENT

This  EMPLOYMENT AGREEMENT (this "Agreement") is entered into effective as of March 10, 2014 (the "Effective Date")
by and between NPS PHARMACEUTICALS, INC., a Delaware corporation, with a business address at 550 Hills Drive, Bedminster, New Jersey 07921, and all its affiliates
(collectively the "Company"), and Paul Firuta (the "Executive"). 

NOW, THEREFORE, the Company and the Executive, in consideration of the mutual promises contained herein, hereby agree as follows:

I.    Employment Agreement 

	The Employment Agreement is hereby stated in its entirety upon the terms set forth below.

II.    Employment, Position and Duties

	Position and Duties.  Effective as of the Effective Date, the Executive will be appointed  President, U.S. Operations, NPS Pharmaceuticals with duties
and responsibilities commensurate with such position, as generally set forth in the Position Description attached hereto and as may change from time to time.   

	Reporting Relationship.  The Executive will report directly to the Chief Operating Officer of the Company (the "COO"); provided, however, for any
period where the Company does not have a COO, the Executive will report directly to the Chief Executive Officer of the Company (the "CEO"). 

	Location.  The Executive will have his primary office at the Company office at 550 Hills Drive, Bedminster, New Jersey.  

	At Will.  Nothing herein is intended to give the Executive the right to be employed by the Company in any capacity or for any duration of time.  The Company
hereby employs Executive on an "at will" basis, and the Company reserves the right to terminate the Executive's employment at any time for any reason.   

	Executive hereby acknowledges that he has a fiduciary responsibility and duty of loyalty to the Company.  For so long as Executive remains employed with the
Company, Executive shall, on a full-time basis, utilize his diligence and his  entire business time, energy, attention, knowledge and skill solely and exclusively to advance
the interests, products and goodwill of the Company.  Executive shall diligently, competently and faithfully perform the duties assigned to him by the Company from time to
time. 

	The duties and services to be performed by Executive hereunder shall be substantially rendered at the Company's principal offices, except for travel on the Company's
business incident to the performance of Executive's duties.  Executive will not, without the written consent of the Board, which consent shall not be unreasonably withheld:
(i) render service to others for compensation, or (ii) serve on any board or governing body of another entity.  If an outside activity subsequently creates a conflict with the
Company's business or prospective business, Executive agrees to cease engaging in such activity at such time.  Executive will observe and adhere to all applicable written
Company policies and procedures adopted from time to time, such as they now exist or hereafter are supplemented, amended, modified or restated.

III.    Compensation

For services rendered hereunder by the Executive, the Company shall pay the Executive the amounts set forth below.

	Base Salary.  As of the Effective Date, the Company shall pay to the Executive an annual base salary of $360,000 (the "Base Salary") payable in
accordance with the standard payroll practices of the Company and less any applicable taxes and withholdings.  In addition, the CEO after review and approval from the
Compensation Committee of the Board of Directors of the Company (the "Compensation Committee"), in its sole and absolute discretion, may determine to
increase such Base Salary for the Executive from time to time; provided, however, nothing contained herein shall obligate the CEO to make such discretionary increases;
provided, further, that the Compensation Committee may determine to reduce such Base Salary so long as such reduction is of a proportionally like amount or percentage
affecting all other senior executives of the Company .

	Short-Term Incentives - Annual Bonus.  The Executive shall be entitled to participate in the Company's current Executive Short-Term Incentive Plan (the
"Bonus Plan") in accordance with the terms of such Bonus Plan, as the same may be amended from time to time. The target bonus opportunity for the
Executive under the Bonus Plan shall be 40% of his Base Salary.  The actual amount of this incentive, or whether the Executive receives an incentive at all, is not
guaranteed.  Also, this target amount is subject to change at the discretion of the Compensation Committee.  Payment of any amount under the Bonus Plan shall be made
in accordance with the terms of the Bonus Plan but not later than March 15 of the fiscal year following the fiscal year for which it is no longer subject to a substantial risk of
forfeiture. 

                                                    2

	Long-Term Incentives - Equity.  The Executive shall be awarded an initial new hire equity grant with a value of $1,250,000 with the value of such grant split 60%
into stock options and 40% into restricted stock units ("RSUs").  The actual number of stock options will be based on the estimated Black-Scholes value of each
share option at the time of grant.  The exercise price of the stock options and the actual number of RSUs will be based on the price for shares of NPS common stock as
quoted on the NASDAQ Stock Market at market close on the date the equity awards are granted.  The awards will be granted on the 15th or next available business day of
the month after the Executive's month of hire (or the next available business day permitted under applicable securities laws to the extent the Company determines
necessary to comply with such laws).  

Subject to the continued employment of Executive by the Company through the applicable vesting dates, and the other applicable terms of such stock options, the
stock options granted pursuant to the above paragraph shall vest over four years as follows: (i) 25% on the first anniversary of the stock option grant date, and (ii) 6.25% on
each quarterly anniversary thereafter.

Subject to the continued employment of Executive by the Company through the applicable vesting dates, and the other applicable terms of such RSUs, the RSUs
granted pursuant to the first paragraph above shall vest equally over three years as follows: (i) one-third on the first anniversary of the RSU grant date, (ii) one-third on the
second anniversary of the RSU grant date, and (iii) one-third on the third anniversary of the RSU grant date.

The Executive will also be entitled to receive future awards granted by the Compensation Committee pursuant to any equity program or long-term incentive plan that
may be maintained by the Company from time to time.  The amount of any future awards shall be determined at the sole and absolute discretion of the Compensation
Committee.  

All equity awards shall be subject to the terms of the applicable equity award agreement and the Company's 2005 Omnibus Incentive Plan (the "2005 Plan")
or other applicable equity plan of the Company.  

IV.    Benefits

The Executive shall be entitled to the employee benefits which are provided to all non-temporary employees of the Company who work a minimum of forty (40)
hours per week and which the Company may revise from time to time or eliminate altogether in its sole and absolute discretion consistent with applicable law.  The terms
and conditions of such benefits shall be governed by the plan documents, insurance policies or Company Policies that may be applicable to each benefit.  As of the
Effective Date, the benefits are as follows:

	Medical insurance coverage for the Executive and his legal dependents as defined by the Company's standard insurance plan.

                                                    3

	Dental insurance coverage for the Executive and his legal dependents as defined by the Company's standard insurance plan.
	Long-term care insurance.
	Short-term disability coverage.
	Term life insurance in the amount of one (1) times the Executive's Base Salary to a maximum of $200,000.
	Accidental death and dismemberment insurance in the amount of one (1) times the Base Salary to a maximum of $200,000.
	Long-term disability coverage.
	401(k) plan.
	Option to participate in the 125 Cafeteria Plan which includes dependent care and health care flexible spending accounts.
	Annual paid time off ("PTO") of twenty-five (25) days per year, with seven and seven-tenths (7.7) hours accrued per full pay period worked.
	Immediate eligibility under the Company's Educational Assistance Policy with an annual limit of $10,000. 
	Relocation assistance under Tier III of the Company's Relocation Policy with a maximum of six (6) months for temporary housing.
	Ten (10) Company holiday days every calendar year.

V.    Restrictive Covenants

The Executive agrees to execute and deliver concurrently with this Agreement to the Company the Employee Agreement Concerning Invention Assignment, Non-Disclosure
and Non-Competition, a copy of which is attached hereto as Exhibit A (the "Restrictive Covenant Agreement").  Executive acknowledges that the
consideration that Executive will receive pursuant to this Agreement serves as sufficient consideration for Executive's promises to abide by the restrictive covenants set
forth in the Restrictive Covenant Agreement.

VI.    Indemnification

The Executive will be indemnified by the Company to the same extent the Company indemnifies other officers and/or directors during and following employment
and/or services as an officer.    The Executive agrees to execute and deliver concurrently with this Agreement to the Company the Indemnity Agreement, a copy of which is
attached hereto as Exhibit B (the "Indemnity Agreement").

VII.    Change In Control Protection

Protection in the Event of a Company Change.  The Executive shall be entitled to participate in the NPS Pharmaceuticals, Inc.  Change in Control
Severance Pay Plan (the "CC Plan") in accordance with the terms of such CC Plan, as the same may be amended from time to time.  Benefits under the CC
Plan shall be paid in lieu of termination benefits under any other provision of this Agreement, and in such case, Executive shall have no right to benefits under
Section VIII.

                                                    4

VIII.    Termination Provisions (other than Change in Control)

	Definitions. For purposes of this Agreement, the following definitions shall apply:

	"Cause" shall mean (a) an act of dishonesty by the Executive in connection with his responsibilities as an employee, (b) the Executive's conviction of, or
plea of nolo contendere to, a felony, (c) the Executive's gross misconduct in connection with the performance or failure of performance of a component of the
Executive's responsibilities as an employee that is injurious to the Company, (d) the Executive's continued substantial violations of his employment duties after he has
received a written demand for performance from the Company which specifically sets forth the factual basis for the Company's belief that the Executive has not
substantially performed such duties and after he has been provided with a sixty (60) day cure period, (e) the Executive's continued poor performance after receiving notice
of the specific areas in which performance is deficient after which performance does not improve over a sixty (60) day cure period, or (f) a violation of a provision of the
Company's Code of Business Conduct and Ethics (or any successor or replacement policy) that the Executive has not performed such duties and after he has been
provided with a sixty (60) day cure period .

	"Good Reason" shall mean, without the express written consent of the Executive, the occurrence of any of the following
conditions, provided the Executive provides notice to the Company of the existence of the condition within ninety (90) days of the initial existence of the condition, the
Company fails to remedy the condition within thirty (30) days of receipt of such notice and the Executive actually resigns from employment within thirty (30) days following
the expiration of the Company's thirty (30) day cure period:  (i) a material relocation (with such change not to be less than 50 miles from 550 Hills Drive, Bedminster, New
Jersey) in the geographic location at which the Executive must perform his services; (ii) any material reduction in the Executive's Base Salary, other than a reduction of a
proportionally like amount or percentage affecting all other senior executives of the Company; (iii) a material diminution in the Executive's authority, duties, responsibilities
or reporting relationships, which shall, without limiting the foregoing, include a change in the Executive's reporting responsibilities as provided in Section II.b. of this
Agreement, or a change in title from President, U.S. Operations; or (iv) any other action or inaction that constitutes a material breach of this Agreement by the Company.

                                                    5

	"Total Disability" shall mean the Executive is unable to engage in any substantial gainful activity by reason of a medically determinable physical or mental
impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, or is, by reason of any medically
determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months,
receiving income replacement benefits for a period of not less than three (3) months under an accident or disability insurance benefit plan covering Company employees,
as determined by the Company in its sole and absolute discretion. 

	Termination by the Company Without Cause.  Except as provided below, if the Company terminates the employment of the Executive without Cause, from
and after such effective date of termination, the Executive shall no longer be entitled to receive any Base Salary, bonus or equity awards, or other amounts or benefits
otherwise payable hereunder, except such continuation and/or conversion rights as required by law or provided under the terms of any Company sponsored
employee benefit plan or agreement executed by the Company and the Executive.  Notwithstanding the foregoing, the Executive shall be entitled to receive the
following:

	Any previously earned and accrued but unpaid Base Salary up to the Executive's date of termination (the "Accrued Base Salary");

	Any unpaid bonus for the calendar year prior to the year in which the termination occurs which may be owed pursuant to the terms of the Bonus Plan described in
Section III.b. above (the "Accrued Bonus");

	Subject to the provisions of Section VIII.f., a lump sum severance payment in an amount equal to one and five tenths (1.5) times the Executive's Base Salary in effect
immediately preceding the date of termination (the "Severance Benefit"); and

	All equity awards shall be treated in accordance with the terms of the 2005 Plan or such other applicable equity plan of the Company or agreement executed by the
Company and the Executive as the same may be in effect from time to time, as applicable, that control such equity awards.

The Company shall, subject to Section III.b., Section IX.k. and the terms and conditions of any applicable plan document(s) or agreement(s), pay all amounts due
under this Section VIII.b. within sixty (60) days following the Executive's effective date of termination.

Nothing above shall be construed as requiring a payment under the Bonus Plan that would not otherwise be required to made under the terms of the Bonus Plan. 

                                                    6

Notwithstanding the foregoing, if the Company terminates the employment of the Executive without Cause following a Change of Control (as defined in the CC Plan as
in effect from time to time), then the Executive shall be entitled only to the payments and rights as provided in Section VII. 

	Termination by the Company For Cause.  Except as provided below, if the Company terminates the employment of the Executive for Cause, as determined
by the Company in its sole and absolute discretion,  from and after such effective date of termination, the Executive shall no longer be entitled to any Base Salary, bonus or
equity awards, or other amounts or benefits otherwise payable hereunder, except such continuation and/or conversion rights as required by law or provided under the
terms of any Company sponsored employee benefit plan or agreement executed by the Company and the Executive. The Executive shall not be entitled to the Severance
Benefit under this Agreement.  This shall be in addition to any forfeiture of rights to unvested stock options or other unvested equity awards, bonuses or other amounts
provided for in any other employee benefit plan, program or agreement of the Company or executed by the Company and the Executive, including, but not limited to the
Bonus Plan and the 2005 Plan.  Notwithstanding the foregoing, the Executive shall be entitled to receive any Accrued Base Salary and Accrued Bonus. All equity awards
shall be treated in accordance with the terms of the 2005 Plan or such other applicable equity plan of the Company or agreement executed by the Company and the
Executive as the same may be in effect from time to time, as applicable, that control such equity awards.  

	Termination as a Result of Death or Disability.  Except as provided below, upon either (i) the death of the Executive or (ii) termination of Executive's
employment by the Company due to a determination by the Company, in its sole and absolute discretion, that the Executive has incurred a Total Disability, the Executive
shall no longer be entitled to any Base Salary, bonus or equity awards, or other amounts or benefits otherwise payable hereunder, except such continuation and/or
conversion rights as required by law or provided under the terms of any Company sponsored employee benefit plan or agreement executed by the Company and the
Executive.  Notwithstanding the foregoing, the Executive or his estate, as applicable, shall be entitled to the following:

	Any Accrued Base Salary; 

	Any Accrued Bonus, and any other bonus that is earned, accrued and due as of the date of the Executive's death or termination for Total Disability, as such date is
determined by the Compensation Committee, in its sole and absolute discretion; and  

	All equity awards shall be treated in accordance with the terms of the 2005 Plan or such other applicable equity plan of the Company or agreement executed by the
Company and the Executive as the same may be in effect from time to time, as applicable, that control such equity awards.

                                                    7

The Company shall, subject to Section III.b., Section IX.k., and the terms and conditions of any applicable plan document(s) or agreement(s), pay all amounts due
under this Section VIII.d. within thirty (30) days following the date of (A) the Executive's death or (B) the Executive's termination due to his Total Disability, as
applicable.

	Termination by Executive for Good Reason.  Except as provided below, if the Executive terminates his employment for Good Reason, the Executive shall no
longer be entitled to receive any Base Salary, bonus or equity awards, or other amounts or benefits otherwise payable hereunder, except such continuation and/or
conversion rights as required by law or provided under the terms of any Company sponsored employee benefit plan or agreement executed by the Company and the
Executive. Notwithstanding the foregoing, the Executive shall be entitled to receive the following:

	Any Accrued Base Salary;

	Any Accrued Bonus; 

	Subject to the provisions of Section VIII.f., the Severance Benefit; and

	All equity awards shall be treated in accordance with the terms of the 2005 Plan or such other applicable equity plan of the Company or agreement executed by
the Company and the Executive as the same may be in effect from time to time, as applicable, that control such equity awards.

The Company shall, subject to Section III.b., Section IX.k., and the terms and conditions of any applicable plan document(s) or agreement(s), pay all amounts due
under this Section VIII.e. within sixty (60) days following the Executive's effective date of termination.

Notwithstanding the foregoing, if the Executive terminates employment with the Company for Good Reason following a Change of Control (as defined in the CC Plan
as in effect from time to time), then the Executive shall be entitled only to the payments and rights as provided in Section VII.

	Release.  The payment of the Severance Benefit is conditioned on the Executive executing, and failing to revoke during any applicable revocation period, a
general release of all claims against the Company and its affiliates in a form prescribed by the Company within fifty days following the Executive's date of termination.

	Voluntary Termination.   Except as provided below, if the Executive terminates his employment without Good Reason, the Executive shall no longer be
entitled to receive any Base Salary, bonus or equity awards, or other amounts or benefits otherwise payable hereunder, except such continuation and/or conversion rights
as required by law or provided under the terms of any Company sponsored employee benefit plan or agreement executed by the Company and the Executive.

                                                    8

Notwithstanding the foregoing, the Executive shall be entitled to receive the following:

	Any Accrued Base Salary;

	Any Accrued Bonus; and

	All equity awards shall be treated in accordance with the terms of the 2005 Plan or such other applicable equity plan of the Company or agreement executed by the
Company and the Executive as the same may be in effect from time to time, as applicable, that control such equity awards.

The Company shall, subject to Section III.b., Section IX.k., and the terms and conditions of any applicable plan document(s) or agreement(s), pay all amounts due
under this Section VIII.g. within sixty (60) days following the Executive's effective date of termination.

	Director/Officer Position Resignation.   Upon the effective date of termination of Executive's employment, for any reason whatsoever, Executive will be
deemed to have resigned from any position Executive may hold as a director and/or officer of the Company and any affiliate of the Company.  The Company is hereby
irrevocably authorized to appoint a nominee to act on Executive's behalf to execute all documents and do all tasks necessary to effectuate this Section VIII.h.

	Return of Property.  Following the termination of Executive's employment by the Company, regardless of the reason for termination, Executive shall return to
Company all Company-owned property in Executive's possession, including but not limited to all keys to buildings or property, credit cards, files, equipment, software and
computers, documents and papers (including but not limited to reports, sales data, product lists, business plans, financial information, corporate governance materials,
notebook entries, and files), telephone cards, cellular telephone(s), and all other Company property.  

	Cooperation after Employment.  

Following the termination of Executive's employment by the Company, regardless of the reason for termination, Executive will reasonably cooperate with the Company
in the prosecution or defense of any claims, controversies, suits, arbitrations or proceedings involving events occurring prior to the termination of this Agreement.
Executive acknowledges that in light of his position, he is in the possession of confidential information that may be privileged under the attorney-client and/or work product
privileges.  Executive agrees to maintain the confidences and privileges of the Company and acknowledges that any such confidences and privileges belong solely to the
Company and can only be waived by the Company, not Executive.  In the event Executive is subpoenaed to testify or otherwise requested to provide information in any
matter, including without limitation, any court action, administrative proceeding or

                                                    9

government audit or investigation, relating to the Company, Executive agrees that: (a) he
will promptly notify the Company of any subpoena, summons or other request to testify or to provide information of any kind no later than three (3) days after receipt of such
subpoena, summons or request and, in any event, prior to the date set for him to provide such testimony or information; (b) he will cooperate with the Company with
respect to such subpoena, summons or request for information; (c) he will not voluntarily provide any testimony or information without permission of the Company unless
otherwise required by law; and (d) he will permit the Company to be represented by an attorney of the Company's choosing at any such testimony or with respect to any
such information to be provided, and will follow the instructions of the attorney designated by the Company with respect to whether testimony or information is privileged by
the attorney-client and/or work product privileges of the Company, unless otherwise required by law.  The parties agree that the Company shall be responsible for all
reasonable expenses of Executive incurred in connection with the fulfillment of Executive's obligations under this Section VIII.j.  The parties agree and acknowledge that
nothing in this Section VIII.j is meant to preclude Executive from fully and truthfully cooperating with any government investigation.

IX.    Miscellaneous Provisions

	Third Party Agreements.  The Executive hereby confirms that the Executive is not bound by the terms of any agreement with any previous employer or
other party which restricts in any way the Executive's use or disclosure of information or the Executive's engagement in any business.  The Executive represents to the
Company that the Executive's execution of this Agreement, the Executive's employment with the Company and the performance of the Executive's proposed duties for the
Company will not violate any obligations the Executive may have to any such previous employer or other party.  In the Executive's work for the Company, the Executive will
not disclose or make use of any information in violation of any agreements with or rights of any such previous employer or other party, and the Executive will not bring to
the premises of the Company any copies or other tangible embodiments of non-public information belonging to or obtained from any such previous employment or other
party.

	Taxes.  All payments under this Agreement shall be made subject to applicable tax withholding, and the Company shall withhold from any payments under
this Agreement all federal, state and local taxes as the Company is required to withhold pursuant to any law or governmental rule or regulation.  The Company has not
made any representation regarding, nor will the Company indemnify the Executive with respect to any tax liability as may be imposed on him in connection with any Base
Salary, bonus or other benefits conferred upon him hereunder; and the Executive shall be liable for all applicable state and federal income taxes, other than the Company's
share of applicable employment taxes, associated therewith.

                                                    10

	Binding Effect.  This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, personal representatives,
successors and assigns, provided that neither party shall assign any of its rights or privileges hereunder without the prior written consent of the other party except that the
Company may assign its rights hereunder to a successor in ownership of all or substantially all the assets of the Company.

	Severability.  Should any part or provision of this Agreement be held unenforceable by a court of competent jurisdiction, the validity of the remaining parts or
provisions shall not be affected by such holding, unless such enforceability substantially impairs the benefit of the remaining portions of this Agreement.

	Captions.  The captions used in this Agreement are for convenience only and are not to be used in interpreting the obligations of the parties under this
Agreement.

	Choice of Law.  The validity, construction and performance of this Agreement and the transactions to which it relates shall be governed by the laws of the
State of New Jersey, without regard to choice of laws provisions.  Each of the parties hereto hereby irrevocably submits to the exclusive jurisdiction of any New Jersey
State Court located in Somerset County or the United States District Court for the District of New Jersey over any action or proceeding arising out of this Agreement or the
employment relationship between them, and each party hereby irrevocably agrees that all claims in respect of such action or proceeding may be held and determined in
such New Jersey State or Federal Court.  

	Entire Agreement.  This Agreement, together with the Restrictive Covenant Agreement, the Indemnity Agreement, and the agreements and plan documents
referenced herein, embodies the entire understanding of the parties as it relates to the subject matter contained herein and as such, supersedes any prior agreement or
understanding between the parties relating to the terms of employment of the Executive.  No amendment or modification of this Agreement shall be valid or binding upon
the parties unless in writing executed by each of the parties.  Notwithstanding the foregoing, any agreement executed by the Company and the Executive that provides for
bonuses, stock options, stock or other grant of value to the Executive, as may exist from time to time, shall, to the extent such agreement explicitly so provides, be deemed
incorporated into this Agreement.

	Notices.  Any and all notices or other communications hereunder shall be sufficiently given if sent by hand, overnight courier or by certified mail, return receipt
requested, postage prepaid, addressed to the party to receive the same, if to Executive, the address on file with the Company, and if to the Company, at its address set
forth on page 1 hereof, or to such other address as the party to receive the same shall have specified by written notice given in a manner provided for in this Section IX.h.
Such notices or other communications shall be deemed to have been given upon receipt if given by hand or by overnight courier and three (3) days after the date deposited
in the mail.

                                                    11

	No Presumption.  Should any of the provisions of this Agreement (including any Exhibit hereto) require judicial interpretation, it is agreed that the court
interpreting or construing this Agreement shall not apply a presumption that any provision shall be more strictly construed against one party by reason of the rule of
construction that a document is to be construed more strictly against the party who itself or through its agents prepared the same, it being agreed that both parties and their
respective agents have participated in the preparation of this Agreement.

	Counterparts.  This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and together which shall
constitute one and the same instrument.

	Section 409A Savings Clause.  This Agreement is intended to comply with the provisions of Section 409A of the Section 409A of the Internal Revenue Code
of 1986, as amended ("Code") (and any regulations and guidelines issued thereunder) to the extent this Agreement is otherwise subject thereto, and this
Agreement shall be interpreted consistent with the requirements of Section 409A of the Code or an applicable exception thereto.  If any compensation or benefits provided
by this Agreement may result in the application of Section 409A of the Code, the Company shall, in consultation with the Executive, exert reasonable efforts to modify the
Agreement in the least restrictive manner necessary in order to exclude such compensation from the definition of "deferred compensation" within the meaning of
such Section 409A of the Code or in order to comply with the provisions of Section 409A of the Code, other applicable provision(s) of the Code and/or any rules,
regulations or other regulatory guidance issued under such statutory provisions and without any diminution in the value of the payments to the Executive.  The Severance
Benefit is intended to be exempt from the requirements of Section 409A pursuant to the short term deferral and separation pay exceptions thereto.  For purposes of Section
409A of the Code, the Severance Benefit will only be paid upon the Executive's "separation from service" within the meaning of such term under Section 409A
of the Code, each payment is a separate payment and a series of installment payments will be treated as a series of separate payments. In no event may the Executive,
directly or indirectly, designate the calendar year of a payment.  In the event the Company determines that the Executive is a Specified Employee (as defined below), then
to the extent necessary to prevent taxation under Section 409A of the Code, any payments to be made to the Executive pursuant to this Agreement shall be delayed until at
least six (6) months after the Executive's termination of employment, and such payments that would otherwise be payable during the six (6) month period following the
Executive's termination of employment shall be paid in a lump sum in the seventh month following such effective date of termination of employment.  For purposes hereof,
"Specified Employee" shall mean any Company employee that the Company determines is a Specified Employee within the meaning of Section 409A of the
Code and the regulations promulgated thereunder.  All reimbursable expenses, any other reimbursements, and in kind benefits, including any third-party payments, provided under this Agreement (or any of the

                                                    12

documents incorporated herein by reference) will be made or provided in accordance with the requirements of Section 409A
of the Code.  Notwithstanding any provision of this Agreement to the contrary, in no event shall the timing of the Executive's execution of the release described in Section
VIII.f., directly or indirectly, result in the Executive designating the calendar year of payment of an amount that is subject to Section 409A of the Code, and if a payment that
is subject to execution of the release and is subject to Section 409A of the Code could be made in more than one taxable year, payment shall be made in the later taxable
year to the extent required to comply with Section 409A of the Code.  The preceding provisions shall not be construed as a guarantee by the Company of any particular tax
effect for payments made pursuant to this Agreement.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

NPS PHARMACEUTICALS, INC.

By: ________________________________       

     Name:  

                              Title:  

 

 

______________________________

Paul Firuta

 

 

                                                    13

EXHIBIT A

                                    EMPLOYEE AGREEMENT CONCERNING       

                                  INVENTION ASSIGNMENT, NON-DISCLOSURE   

                                  AND NON-COMPETITION

Employee: Paul Firuta 

In consideration of employment or continued employment by NPS Pharmaceuticals, Inc. (which together with its affiliates and subsidiaries, if any, are hereinafter
referred to as the "Company"), the compensation paid by the Company from time to time and other good and valuable consideration, Employee hereby represents to and
agrees with the Company as follows:

	Scope of Company's Business Interests.

Employee understands that the Company is engaged in a continuous program of research, development, production, and marketing with respect to
the discovery and development of novel pharmaceutical therapies for a variety of diseases.

	Definitions.

2.1   "Confidential Information" shall mean:

2.1.1   any and all Intellectual Property or information whether business, financial, technical or otherwise, of any type whatsoever, in any form
whatsoever, which is (a) proprietary to the Company; or (b) submitted or disclosed to the Company by a third party. 

2.1.2   Confidential Information (whether or not reduced to writing and in any and all stages of development) includes but is not limited to:  discoveries,
ideas, inventions, designs, formulas, test results, test procedures, protocols, concepts, drawings, specifications, techniques, models, data, software, research, processes,
procedures, works of authorship, formulas, improvements, trade secrets, know-how, marketing plans and supplies, product plans, customer names (and other information
relating to customers), supplier names (and other information relating to suppliers), and financial information. 

2.1.3   Confidential Information shall not include anything that is publicly known or generally employed by the trade at or after the effective date of this
Agreement. 

2.2   "Intellectual Property" shall mean, without limitation, all copyrights, patents, trademarks, service marks, trade secrets, know-how and other
rights commonly referred to as "moral rights" and all intellectual property rights of any type whatsoever.

                                                    1

	Assignment of Rights in Intellectual Property.

3.1Employee hereby assigns to the Company all of Employee's rights in all discoveries, inventions and other technology, all works of
authorship, all data and information, and all Intellectual Property rights therein and thereto, which are made, discovered, developed, assembled, created, or conceived, in
whole or in part, previously or hereafter by Employee:  (a) during the course of and within the scope of employment with the Company; or (b) with the aid of Confidential
Information or the facilities, resources or property of the Company.

3.2All of said Intellectual Property assigned to the Company shall be Confidential Information except for anything that is publicly known or
generally employed by the trade, without the fault of Employee, at or after the effective date of this Agreement.

3.3Employee agrees to disclose promptly and fully to the Company anything which qualifies as Confidential Information hereunder.

	Confidential Information.

4.1Employee understands that Confidential Information is confidential and secret and agrees to respect the confidentiality and secrecy of the
same.  Employee also understands that all Confidential Information is the property of the Company or of a third party submitting the same to the Company.  Employee
agrees to treat Confidential Information submitted to the Company by third parties as if confidential and proprietary to the Company.

4.2Except as lawfully authorized or as may be required in the performance of Employee's responsibilities for the Company, Employee:

4.2.1agrees not to directly or indirectly disclose, reveal, report, publish, or transfer possession of, or access to, any Confidential Information to
any person or entity;

4.2.2agrees, at the expense of the Company, promptly at all times hereafter to execute and deliver any and all acts and instruments as may be
necessary or desirable to perfect and protect the Company's interest in the Confidential Information; and

4.2.3agrees not to directly or indirectly use the Confidential Information except for the benefit of the Company in the performance of
Employee's responsibilities for the Company.

	Trust Relationship.

Employee understands that employment with the Company creates a relationship of confidence and trust between the Employee and the Company
with respect to the Employee's care, use, and treatment of Intellectual Property and Confidential Information of the Company.

                                                    2

	Delivery to the Company.

Employee agrees to turn over any and all Confidential Information in Employee's possession or control upon request of the Company and upon
termination of employment with the Company.  Employee understands and agrees that Employee's obligations under this Agreement survive the termination of Employee's
employment with the Company.

	No Contract of Employment.

7.1Nothing herein is intended to constitute a contract of employment or alter or change the terms of Employee's understanding with the
Company concerning terms and duration of employment.

7.2This Agreement is not an employment agreement and does not give the Employee the right to be employed by the Company in any
capacity.  The    Company reserves the right to terminate Employee's employment at any time for any reason, subject to Employee's rights under his Employment
Agreement.

	Non-Competition.

8.1The Employee understands and agrees  that the Company's activities, including its interests in Confidential Information and Intellectual
Property, are of a proprietary, unique and special nature and that if Employee's services were used in competition with the Company, such use could cause serious and
possibly irreparable harm to the Company.  Accordingly, Employee agrees to the commitments of non-competitive activities as described herein.

8.1.1Employee agrees that during the period of employment with the Company and for a period of one year thereafter, Employee shall not,
directly or indirectly, whether as owner, partner, shareholder, consultant, agent, employee, co-venturer or otherwise, engage, participate, assist or invest in any business
whose products or activities complete in whole or in part with the products or activities of the Company anywhere in the world, provide, however, that this does not apply to
investments in mutual funds, or in public companies where the employee's investment is less than one (1%) of the outstanding stock of a publicly held corporation or five
percent (5%) of the employee's total liquid assets.

8.1.2Employee agrees that during the period of employment with the Company, and for a period of one year thereafter, Employee shall not
directly or indirectly (a) call on, solicit, take away, or attempt to take away for the benefit of Employee or of any other person or entity, any customer, supplier, or client of
the Company whether or not Employee had personal contact with such person during employment with the Company, or (b) solicit, take away, or attempt to take away, for
the benefit of the Employee or of any other person or entity, any employee or officer of the Company.

8.1.3Employee agrees that upon termination of employment with the Company, Employee shall not use or disclose material Confidential
Information of the Company.

                                                    3

	No Use of Other's Intellectual Property.

Employee represents to the Company that Employee has not brought and has not used, and agrees that it will not bring to the Company and will not
use in the performance of any responsibilities for the Company, any information, materials or the like which are confidential and are proprietary to a former employer or to
some other person or entity without written authorization from said former employer, person or entity.

	Injunctive Relief.

Employee agrees that, because of the unique nature of this Agreement and the obligations of Employee regarding non-disclosure, non-use and
assignment of inventions and Intellectual Property, monetary damages alone will be an inadequate remedy for Employee's breach of such obligations.  As a result,
Employee agrees that the Company shall be entitled to obtain injunctive and other equitable relief to protect the confidential nature of its Confidential Information and its
interest in such inventions and Intellectual Property, in addition to all other remedies which may be available at law or otherwise.

	Miscellaneous.

11.1 If any provision of this Agreement is determined by a court of competent jurisdiction to be invalid or unenforceable, the same shall be
deemed severed from the remainder of this Agreement and shall not cause the invalidity or unenforceability of the remainder of this Agreement.  However, if the provisions
of section 8 above are determined by a court of competent jurisdiction to be unenforceable because of its temporal or geographic limitation(s), the parties agree that any
such court may modify such limitation(s) so as to render it/them enforceable.

11.2This Agreement shall be governed by the laws of the State of New Jersey without reference to the conflicts of law principles thereof.

11.3This Agreement constitutes the final, complete, and exclusive agreement between the Company and Employee concerning the subject
matter of this Agreement and supersedes all prior representations, agreements, understandings, negotiations and discussions, written or oral, between the Company and
Employee with respect thereto.  In the event Employee and the Company have previously entered into an agreement concerning the subject matter hereof, this Agreement
is considered a novation of that agreement.  Employee agrees that all Confidential Information received by Employee prior to the "Date of Hire" shown below is governed
hereby and is deemed received pursuant to the terms hereof.  Any inventions excluded by Employee thereunder are also deemed excluded hereunder unless stated
otherwise in Exhibit A hereof.  Any modification, recision or amendment of this Agreement shall not be effective unless made in writing and executed by both parties.

                                                    3

11.4Employee has identified in the space below all inventions, ideas, biological compounds, cell lines, and other items of Intellectual Property
of interest to the Company as described herein, and other items of Intellectual Property which have been made or conceived or first reduced to practice by Employee, alone
or jointly with others, PRIOR to employment with the Company AND which Employee desires to exclude from the operation of this Agreement.  Employee claims an interest
in the following PRIOR items of Intellectual Property:

 __________________________________________________________________

 __________________________________________________________________

If no inventions, ideas, discoveries or other items of Intellectual Property are identified in the space above, then Employee represents that there are
no such inventions, ideas, discoveries or other items of Intellectual Property.

11.5Employee agrees that adequate consideration to the Employee from the Company can be found in each of the following:

11.5.1continued employment with the Company;

11.5.2compensation paid to the Employee by the Company from time to time; and

11.5.3capital stock of the Company sold or granted to the Employee from time to time.

11.6Employee acknowledges that his employment with the Company was expressly conditioned upon an understanding that an agreement
covering the subject hereof was a condition of employment and that this Agreement is the intended agreement and that if signed after the Date of Hire the Agreement is
intended to relate back to the Employee's Date of Hire and to be part of the terms of initial employment.

	
READ, UNDERSTOOD AND ACCEPTED: 

EMPLOYEE:

__________________________

                   (Signature)

                   Dated: _______________________

                   Date of Hire: ___________________________
	 	
WITNESSED BY COMPANY:

NPS PHARMACEUTICALS, INC.

By: _____________________

                    Its: SVP, Human Resources     

                   Dated: _____________________

	 	 	 

                                                    5

EXHIBIT B

INDEMNITY AGREEMENT

THIS AGREEMENT, effective the 10th day of March , 2014, by and between NPS Pharmaceuticals, Inc., a Delaware corporation (the
"Corporation"), and Paul Firuta, the undersigned agent of the Corporation ("Agent").

RECITALS

WHEREAS, Agent performs a valuable service to the Corporation in the capacity as an officer of the Corporation;

WHEREAS, the stockholders of the Corporation have adopted bylaws (the "Bylaws") providing for the indemnification of the directors, officers, employees,
and other agents of the Corporation, including persons serving at the request of the Corporation in such capacities with other corporations or enterprises, as authorized by
the Delaware General Corporation Law, as amended (the "Code");

WHEREAS, the Bylaws and the Code, by their non-exclusive nature, permit contracts between the Corporation and its agents, officers, employees, and other agents
with respect to indemnification of such persons; and

WHEREAS, in order to induce Agent to continue to serve as an officer of the Corporation, the Corporation has determined and agreed to enter into this Agreement with
Agent;

NOW, THEREFORE, in consideration of Agent's continued service as an officer after the date hereof, the parties hereto agree as follows:

	Services to the Corporation. With duties beginning as of the above date, Agent will serve, at the will of the Corporation or under separate contract, if any such
contract exists, as an officer of the Corporation or as a director, officer or other fiduciary of an affiliate of the Corporation (including any employee benefit plan of the
Corporation) faithfully and to the best of Agent's ability so long as Agent is duly elected and qualified or appointed in accordance with the provisions of the Bylaws or other
applicable charter documents of the Corporation or such affiliate; provided, however, that Agent may at any time and for any reason resign from such position (subject to
any contractual obligation that Agent may have assumed apart from this Agreement) and that the Corporation or any affiliate shall have no obligation under this Agreement
to continue Agent in any such position.

	Indemnity of Agent. The Corporation hereby agrees to hold harmless and indemnify Agent to the fullest extent authorized or permitted by the provisions of the
Bylaws, the Code, and applicable law as the same may be amended from time to time (but, only to the extent that such amendment permits the Corporation to provide
broader indemnification rights than the Bylaws, the Code, or applicable law permitted prior to adoption of such amendment).

	Additional Indemnity. In addition to and not in limitation of the indemnification otherwise provided for herein, and subject only to the exclusions set forth in
Section 4 hereof, the Corporation hereby further agrees to hold harmless and indemnify Agent:

                                                    1

	against any and all expenses (including attorneys' fees), witness fees, damages, judgments, fines, amounts paid in settlement, and any other amounts that Agent
becomes legally obligated to pay because of any claim or claims made against or by Agent in connection with any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, arbitrational, administrative, or investigative (including an action by or in the right of the Corporation) to which Agent is, was or at any
time becomes a party, or is threatened to be made a party, by reason of the fact that Agent is, was or at any time becomes a director, officer, employee or other agent of
Corporation, or is or was serving or at any time serves at the request of the Corporation as a director, officer, employee or other agent of another corporation, partnership,
joint venture, trust, employee benefit plan or other enterprise; and

	otherwise to the fullest extent as may be provided to Agent by the Corporation under the non-exclusivity provisions of the Code and Section 11.5 of the
Bylaws.

	Limitations on Additional Indemnity. No indemnity shall be paid by the Corporation under this agreement:

	on account of any claim against Agent for an accounting of profits made from the purchase or sale by Agent of securities of the Corporation pursuant to the provisions
of Section 16(b) of the Securities Exchange Act of 1934 and amendments thereto or similar provisions of any federal, state or local statutory law;

	on account of Agent's conduct that was knowingly fraudulent or deliberately dishonest or that constituted willful misconduct;

	on account of Agent's conduct that constituted a breach of Agent's duty of loyalty to the Corporation or resulted in any personal profit or advantage to which Agent was
not legally entitled;

	for which payment is actually made to Agent under a valid and collectible insurance policy or under a valid and enforceable indemnity clause, bylaw or agreement,
except in respect of any excess beyond payment under such insurance, clause, bylaw or agreement;

	if indemnification is not lawful (and, in this respect, both the Corporation and Agent have been advised that the Securities and Exchange Commission believes that
indemnification for liabilities arising under the federal securities laws is against public policy and is, therefore, unenforceable and that claims for indemnification should be
submitted to appropriate courts for adjudication); or

	in connection with any proceeding (or part thereof) initiated by Agent, or any proceeding by Agent against the Corporation or its directors, officers, employees or other
agents, unless (i) such indemnification is expressly required to be made by law, (ii) the proceeding was authorized by the Board of Directors of the
Corporation, (iii) such indemnification is provided by the Corporation, in its sole discretion, pursuant to the powers vested in the Corporation under the Code, or
(iv) the proceeding is initiated pursuant to Section 9 hereof.

                                                    2

	Continuation of Indemnity. All agreements and obligations of the Corporation contained herein shall continue during the period Agent is a director, officer,
employee or other agent of the Corporation (or is or was serving at the request of the Corporation as a director, officer, employee or other agent of another corporation,
partnership, joint venture, trust, employee benefit plan or other enterprise) and shall continue thereafter so long as Agent shall be subject to any possible claim or
threatened, pending or completed action, suit or proceeding, whether civil, criminal, arbitrational, administrative or investigative, by reason of the fact that Agent was
serving in the capacity referred to herein.

	Partial Indemnification. Agent shall be entitled under this Agreement to indemnification by the Corporation for a portion of the expenses (including attorneys'
fees), witness fees, damages, judgments, fines and amounts paid in settlement, and any other amounts that Agent becomes legally obligated to pay in connection with any
action, suit or proceeding referred to in Section 3 hereof even if not entitled hereunder to indemnification for the total amount thereof, and the Corporation shall
indemnify Agent for the portion thereof to which Agent is entitled.

	Notification and Defense of Claim. Not later than thirty (30) days after receipt by Agent of notice of the commencement of any action, suit or proceeding,
Agent will, if a claim in respect thereof is to be made against the Corporation under this Agreement, notify the Corporation or confirm that the Corporation has notice of the
commencement thereof; but the omission so to notify or so to confirm notice to the Corporation will not relieve it from any liability which it may have to Agent otherwise than
under this Agreement. With respect to any such action, suit or proceeding as to which Agent notifies the Corporation of the commencement thereof or confirms that the
Corporation has such notice:

	the Corporation will be entitled to participate therein at its own expense;

	except as otherwise provided below, the Corporation may, at its option and jointly with any other indemnifying party similarly notified and electing to assume such
defense, assume the defense thereof, with counsel reasonably satisfactory to Agent. After notice from the Corporation to Agent of its election to assume the defense
thereof, the Corporation will not be liable to Agent under this Agreement for any legal or other expenses subsequently incurred by Agent in connection with the defense
thereof except for reasonable costs of investigation or otherwise as provided below. Agent shall have the right to employ separate counsel in such action, suit or
proceeding but the fees and expenses of such counsel incurred after notice from the Corporation of its assumption of the defense thereof shall be at the expense of Agent
unless (i) the employment of counsel by Agent has been authorized by the Corporation, (ii) Agent shall have reasonably concluded that there may be a conflict
of interest between the Corporation (or any other agent or agents for whom the Corporation has assumed or may assume the defense) and Agent in the conduct of the
defense of such action; or (iii) the Corporation shall not in fact have employed counsel to assume the defense of such action, in each of which cases the fees and
expenses of Agent's separate counsel shall be at the expense of the Corporation. The Corporation shall not be entitled to assume the defense of any action, suit or
proceeding brought by or on behalf of the Corporation or as to which Agent shall have made the conclusion provided for in clause (ii) above; and

                                                    3

	the Corporation shall not be liable to indemnify Agent under this Agreement for any amounts paid in settlement of any action or claim effected without its written
consent, which shall not be unreasonably withheld. The Corporation shall be permitted to settle any action except that it shall not settle any action or claim in any manner
that would impose any penalty or limitation on Agent without Agent's written consent, which may be given or withheld in Agent's sole discretion.

	Expenses. Promptly following request for advancement of expenses and upon receipt of an undertaking by or on behalf of Agent to repay said amounts on
the terms hereof, the Corporation shall advance, prior to the final disposition of any proceeding, all expenses actually and reasonably incurred by Agent in connection with
such proceeding, prior to the date (if at all) when the Corporation has determined that Agent has acted in bad faith or in a manner that Agent did not believe to be in or not
opposed to the best interests of the Corporation, that Agent is not entitled to indemnification due to exclusion under Section 4 hereof or, with respect to any criminal action
or proceeding that Agent acted without reasonable cause to believe that Agent's conduct was lawful. Such determination may be made by the Corporation upon a finding
that the facts known to the decision-making party at the time such determination is made, clearly and convincingly support such a determination. Such determination may
be made by the Corporation (i) as to an officer by a vote of all disinterested directors provided such directors constitute a quorum of the Board of Directors; or (ii) if such a
quorum is not obtainable, or even if obtainable, upon direction of a majority of the disinterested directors as to an officer or director by independent legal counsel (selected
by said majority, or other representation of the Corporation, from a panel of five alternates approved for this purpose by the National Association of Corporate Directors) in
a written opinion. This provision is adopted under and is to be interpreted consistent with Delaware Code 145(f) and Bylaw 11.5.

	Enforcement.

	Any right to indemnification or advances granted by this Agreement to Agent shall be enforceable by or on behalf of Agent in any court of competent jurisdiction if
(i) the claim for indemnification or advances is denied, in whole or in part, or (ii) no disposition of such claim is made within ninety (90) days of request therefor.
Agent, in such enforcement action, if successful in whole or in part, shall be entitled to be paid also the expense of prosecuting Agent's claim. It shall be a defense to any
action for which a claim for indemnification is made under Section 3 hereof (other than an action brought to enforce a claim for expenses pursuant to Section 8
hereof, provided that the required undertaking has been tendered to the Corporation) that Agent is not entitled to indemnification because of the limitations set forth in
Section 4 hereof.   Neither the failure of the Corporation (including its Board of Directors or its stockholders) to have made a determination prior to the
commencement of such enforcement action that indemnification of Agent is proper in the circumstances, nor an actual determination by the Corporation (including its Board
of Directors or its stockholders) that such indemnification is improper shall be a defense to the action or create a presumption that Agent is not entitled to indemnification
under this Agreement or otherwise.

                                                    4

	Any determination, election, or authorization (a "Determination") permitted or required herein to be made by the Corporation when made by the Board of
Directors, shall be made in the manner set out in the following sentence when the Determination is (i) to authorize Agent to initiate a proceeding against the Corporation
under paragraph 4(f) hereof; (ii) to participate in a proceeding under paragraph 7(a) hereof; or (iii) to assume the defense under paragraph 7(b) hereof. A Determination
made by the Board of Directors under the proceeding sentence shall require only a quorum of one-third of the exact number of directors of the Corporation fixed from time
to time in accordance with the Certificate of Incorporation if such Determination is to authorize Agent to bring an action under (i) above, to cause the Corporation to
participate in a proceeding under (ii) above, and/or to assume a defense of an action against Agent under (iii) above.

	Subrogation. In the event of payment under this Agreement, the Corporation shall be subrogated to the extent of such payment to all of the rights of recovery
of Agent, who shall execute all documents required and shall do all acts that may be necessary to secure such rights and to enable the Corporation effectively to bring suit
to enforce such rights.

	Non-Exclusivity of Rights. The rights conferred on Agent by this Agreement shall not be exclusive of any other right which Agent may have or hereafter
acquire under any statute, provision of the Corporation's Certificate of Incorporation or Bylaws, agreement, vote of stockholders or directors, applicable law or otherwise,
both as to action in Agent's official capacity and as to action in another capacity while holding office.

	Survival of Rights.

	The rights conferred on Agent by this Agreement shall continue after Agent has ceased to be a director, officer, employee or other agent of the Corporation or to serve
at the request of the Corporation as a director, officer, employee or other agent of another corporation, partnership, joint venture, trust, employee benefit plan or other
enterprise and shall inure to the benefit of Agent's heirs, executors and administrators.

	The Corporation shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business or
assets of the Corporation, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Corporation would be required to
perform if no such succession had taken place.

	Separability. Each of the provisions of this Agreement is a separate and distinct agreement and independent of the others, so that if any provision hereof shall
be held to be invalid for any reason, such invalidity or unenforceability shall not affect the validity or enforceability of the other provisions hereof. Furthermore, if this
Agreement shall be invalidated in its entirety on any ground, then the Corporation shall nevertheless indemnify Agent to the fullest extent provided by the Bylaws, the Code
or any other applicable law.

	Governing Law. This Agreement shall be interpreted and enforced in accordance with the laws of the State of Delaware, without regard to choice of law
provisions.

	Amendment and Termination. No amendment, modification, termination or cancellation of this Agreement shall be effective unless in writing signed by both
parties hereto.

                                                    5

	Identical Counterparts. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of
which together shall constitute but one and the same Agreement. Only one such counterpart need be produced to evidence the existence of this Agreement.

	Headings. The headings of the sections of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or
to affect the construction hereof.

	Notices. All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given
(i) upon delivery if delivered by hand to the party to whom such communication was directed, or (ii) upon the third (3rd) business day after the
date on           which such communication was mailed if mailed by certified or registered mail with postage prepaid:

	If to Agent, to the address on file with the Corporation.

	If to the Corporation, to:

NPS Pharmaceuticals, Inc.

   550 Hills Dr., 3rd Floor

   Bedminster, NJ  07921

   Attention:  SVP, Human Resources

or to such other address as may have been furnished to Agent by the Corporation.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.

	
AGENT

/s/ Paul Firuta                

Paul Firuta 

	 	
NPS PHARMACEUTICALS, INC.

By: /s/ Glenn R. Melrose                

	 	 	
Glenn R. Melrose

          SVP, Human Resources

	 	 	 

                                                    6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00230-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00230-of-00352.parquet"}]]